[The prevention of postoperative deep venous thrombosis with heparan sulfate per os. A controlled clinical study vs. heparin calcium]. 1992

M Seccia, and M G Bellomini, and O Goletti, and A Tortora, and P Buccianti, and M Chiarugi, and A Bertolucci, and M C Martino, and C Macaluso, and E Cavina
Cattedra di Chirurgia d'Urgenza, Università degli Studi di Pisa.

The paper reports the results of a randomised study carried out on a pool of 100 patients undergoing surgery in order to assess the efficacy and tolerability of orally administered heparan sulfate versus heparin calcium in the prevention of postoperative deep-vein thrombosis. Despite the limits of oral administration, heparan sulfate is indicated in the pharmacological prevention of postoperative deep-vein thrombosis.

UI MeSH Term Description Entries
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006497 Heparitin Sulfate A heteropolysaccharide that is similar in structure to HEPARIN. It accumulates in individuals with MUCOPOLYSACCHARIDOSIS. Heparan Sulfate,Sulfate, Heparan,Sulfate, Heparitin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D013514 Surgical Procedures, Operative Operations carried out for the correction of deformities and defects, repair of injuries, and diagnosis and cure of certain diseases. (Taber, 18th ed.). Surgical Procedures,Ghost Surgery,Operative Procedures,Operative Surgical Procedure,Operative Surgical Procedures,Procedure, Operative Surgical,Procedures, Operative Surgical,Surgery, Ghost,Surgical Procedure, Operative,Operative Procedure,Procedure, Operative,Procedure, Surgical,Procedures, Operative,Procedures, Surgical,Surgical Procedure
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides

Related Publications

M Seccia, and M G Bellomini, and O Goletti, and A Tortora, and P Buccianti, and M Chiarugi, and A Bertolucci, and M C Martino, and C Macaluso, and E Cavina
September 1988, Minerva medica,
M Seccia, and M G Bellomini, and O Goletti, and A Tortora, and P Buccianti, and M Chiarugi, and A Bertolucci, and M C Martino, and C Macaluso, and E Cavina
March 1974, Lancet (London, England),
M Seccia, and M G Bellomini, and O Goletti, and A Tortora, and P Buccianti, and M Chiarugi, and A Bertolucci, and M C Martino, and C Macaluso, and E Cavina
January 1987, Minerva dietologica e gastroenterologica,
M Seccia, and M G Bellomini, and O Goletti, and A Tortora, and P Buccianti, and M Chiarugi, and A Bertolucci, and M C Martino, and C Macaluso, and E Cavina
March 1990, Minerva ginecologica,
M Seccia, and M G Bellomini, and O Goletti, and A Tortora, and P Buccianti, and M Chiarugi, and A Bertolucci, and M C Martino, and C Macaluso, and E Cavina
June 1987, Minerva medica,
M Seccia, and M G Bellomini, and O Goletti, and A Tortora, and P Buccianti, and M Chiarugi, and A Bertolucci, and M C Martino, and C Macaluso, and E Cavina
June 1971, Lancet (London, England),
M Seccia, and M G Bellomini, and O Goletti, and A Tortora, and P Buccianti, and M Chiarugi, and A Bertolucci, and M C Martino, and C Macaluso, and E Cavina
November 1976, British medical journal,
M Seccia, and M G Bellomini, and O Goletti, and A Tortora, and P Buccianti, and M Chiarugi, and A Bertolucci, and M C Martino, and C Macaluso, and E Cavina
January 1983, Vojnosanitetski pregled,
M Seccia, and M G Bellomini, and O Goletti, and A Tortora, and P Buccianti, and M Chiarugi, and A Bertolucci, and M C Martino, and C Macaluso, and E Cavina
January 1990, Phlebologie,
M Seccia, and M G Bellomini, and O Goletti, and A Tortora, and P Buccianti, and M Chiarugi, and A Bertolucci, and M C Martino, and C Macaluso, and E Cavina
February 1988, Nihon Geka Gakkai zasshi,
Copied contents to your clipboard!